Grand Rounds Recap 8.17.22


Ultrasound in Cardiac Arrest WITH Dr. Stolz

General Epidemiology

  • Out of hospital cardiac arrest causes are almost as varied as patients themselves. We must both avoid anchoring to a certain etiology while treating the presumed cause of arrest. 

    • ~30% of OHCA will survive to hospital admission 

    • ~10 % of OHCA will survive to hospital Discharge 

    • ~8% of OHCA will survive with good neurologic function

  • How can we use Ultrasound as an aid to improve 

    • Goal

      • Differentiate Organized cardiac rhythm from Asystole, True PEA and PseudoPEA

        • PEA - Organized electrical activity without palpable pulses

        • True PEA Organized electrical activity without cardiac motion

        • PseudoPEA-organized electrical activity without a palpable pulse with organized cardiac motion

      • Find reversible causes of cardiac arrest

      • Guide procedures

    • In observational studies Ultrasound has been shown to improve survival in OHCA and in-ED cardiac arrest (Here)

    • In patients with a PEA arrest who achieved rosc 43% have been seen to have cardiac activity on US

  • Cardiac Activity on Ultrasound 

    • Many different definitions and hard to come to a consensus but ventricular wall motion is likely the most agreed upon predictor. 

  • Reversible causes which are identifiable on Ultrasound

    • Hypovolemia 

    • Tension Pneumothorax

    • Tamponade

    • PE 

  • Ultrasound as a Hindrance to resuscitation 

    • Pulse check duration

      • Multiple studies have shown that pulse checks with ultrasound take longer and longer time without compressions is bad

      • This is a modifiable behavior which can be changed to create parity between ultrasound and non-ultrasound pulse checks

    • Interference with needed interventions

      • Ultrasound is not an IV. ​

      • It is not airway support. ​

      • It is not chest compressions.​

      • Ultrasound needs to take a backseat to all of these things.

      • Best done after initial vital interventions are done​

        • ACCESS, MONITOR, AIRWAY iGel, oxygen​

        • LUCAS

    • Accuracy

      • There has been seen to be little agreement between interpretation of cardiac stand still on ultrasound by EM physicians, cardiologists,intensivists, faculty, fellows, and residents. 

      • Confounders

        • Mechanical Ventilation can cause valve flutter

        • Bradycardia can complicate pulse checks

        • RV dilation occurs to some extant after cardiac arrest for multiple reasons 

          • Hypoxia, pulmonary vasoconstriction, PA pressure elevation, RV afterload 

  • Best Practices in Cardiac Arrest POCUS

    • PRO-10

    • Prepare before the pause 

      • Coordinate so probe is in place prior to pulse check 

      • This makes pulse checks faster

    • Review after CPR resumes

      • Take a clip during the Pause in CPR 

      • Review the clip once CPR has resumed

      • Consider

        • Cardiac activity

        • Pericardial effusion

        • LV size/function

        • RV size/function

    • Other provider performs the US

      • This allows the Resuscitationist to offload this cognitive burden and will allow images to be acquired with less delay 

    • <10s duration pause in CPR

      • Set clip duration to 10 seconds

      • Assign a count down person

      • Ignore the person doing the ultrasound 


Not Another Boring Lecture WITH Dr. Santen, Broadstock and Zalesky

  • Learners retain

  • 5-10% by reading

  • 5-30% by hearing

  • 20-40% with audiovisual

  • 30% demonstration

  • 50% with discussion

  • 70% with saying the information

  • 90% say, hear and do

  • 90% if they have to teach others 

  • Techniques to improve lectures in a lecture hall style room

    • Muddiest point: have learners write down the most confusing part of the lecture

    • 1 minute paper: take one minute to write down what you have learned

    • Pretest: test the audience on the information before the teaching. This primes them on what to listen to and identifies knowledge gaps. This is followed by a post test to show knowledge acquisition. 

    • Round table discussion: make people engage in the conversation 

    • Fishbowl: pulls people up front and others watch them have the conversation. People can tap out and have others fill the role

    • More Resources found here 

  • Topics covered

    • TEG resuscitation

    • Uveitis 

      • Ddx of red eye:

        • extra-ocular causes (e.g. orbital cellulitis, cavernous sinus thrombosis, carotid-cavernous fistula, cluster headache)

        • external eye disease (e.g. eyelid and conjunctival disease)

        • internal eye disease (e.g. iritis, glaucoma)

      • If extra-ocular cause is excluded, determine:

        • Painful:

        • abnormal cornea

          • e.g. herpes simplex keratitis, corneal ulcer, marginal keratitis, corneal abrasion, chemical burn

        • abnormal eyelid

          • e.g. chalazion/stye, acute blepharitis, herpes zoster ophthalmicus

        • diffuse conjunctival injection

          • e.g. viral conjunctivitis, allergic conjunctivitis, bacterial conjunctivitis (including chlamydia), dry eyes, acute glaucoma

        • ciliary injection/ scleral involvement

          • e.g. scleritis, episcleritis

        • anterior chamber involvement

          • e.g. acute anterior uveitis (iritis) from autoimmune disease, traumatic iritis, hypopyon, hyphema

        • Other: ocular foreign body, globe rupture, endophthalmitis

      • Painless:

        • Diffuse

          • usually this is an eyelid abnormality as most cases of conjunctivitis are painful: e.g. blepharitis, ectropion, trichiasis, entropion, eyelid lesion (e.g. tumor, stye)

        • Localized

          • e.g. pterygium, corneal foreign body, ocular trauma, subconjunctival hemorrhage

        • Other: leptospirosis, kawasaki disease, adenovirus

      • Workup:

        • pupillary examination, visual acuity, slit-lamp exam (cell/flare), fluorescein staining, tonometry

        • ESR/CRP, RPR, HIV, Toxo

      • Diagnosis:

        •  ocular syphilis can affect several parts of the eye (briefly cover anterior vs posterior chamber)

        • This is often panuveitis (anterior and posterior), posterior uveitis (chorioretinitis), or more rarely anterior uveitis (iritis). Among patients with anterior uveitis, they are more likely to be HIV+


Supreme Court Ruling Dobbs v Jackson: Emergency Medicine Implications WITH Dr. Pensak

  •  Review the history of abortion care in the US and the State of Ohio.​

  • 81% of people in the US believe that abortion care should be legal (Gallup 2021)​

  • 40% of pregnancies conclude with abortion care ​

  • 1 in 4 people who can get pregnant have abortion care in their lifetime​

  • Abortion care is very safe ​

    • Mortality from abortion care is 0.41 per 100,000 (2018)​

    • Mortality from pregnancy & delivery is 17.3 per 100,000 (2017)​

    • The need for abortion care is concentrated in communities with limited access to comprehensive health care, including contraceptive care​

    • These are the communities least able to overcome barriers to care​

  • Safety of Abortion care in the US

    • “The committee concludes that the quality of abortion care depends on where a woman lives. In many states, regulations have created barriers to safe, effective, patient-centered, timely, efficient, and equitable abortion services. The regulations often prohibit qualified providers from providing services, misinform women of the risks of the procedures they are considering, overrule women’s and clinician’s medical decision making, or require medically unnecessary services and delays in care.”​

  • History of Abortion Care in the US

    • Early 1800s: Abortion was common and legal before quickening​

    • Late 1800s: Abortion was criminalized in each state, with exceptions for the health/life of the pregnant person​

    • By mid 1900s, illegal abortion became a leading cause of pregnancy-related death ​

    • Contraceptive counseling and care was illegal in many states​

    • 1960s: 1/10 low-income women had ever attempted illegal abortion​

    • 1968, LAC-USC admitted 701 women with septic abortions, one admission for every 14 deliveries.​

    • Early 1960s NYC: double rate of perinatal deaths in Puerto Rican pts vs white pts​

    • 1972-1974: the mortality rate due to illegal abortion for nonwhite women was 12 times that for white women.​

    • ​Prior to Roe v Wade abortion did occur in the US​

      • Estimated 1.2 million illegal abortions per year​

      • Nearly 5000 deaths a year​

      • After Roe v Wade deaths due to septic abortion dropped precipitously​

    • 1973 Roe V Wade

      • June 1969 Norma McCorvey sought abortion but could not access, talked out of seeking illegal abortion​

      • Gave birth June 1970 - put baby up for adoption​

      • June 1970, case brought against state to Fifth Circuit court, Texas law declared unconstitutional​

      • Violates right to privacy (9th amendment)​

      • No injunction against enforcing law​

      • Case originally argued Dec 1971, reargued October 1972​

      • Decided 1973: SCOTUS rules that the 14th amendment protects a women’s right to abortion under the Due Process Clause. Created pregnancy trimesters. ​

    • The Number of deaths from abortion has declined dramatically since Roe v. Wade

    • Planned Parenthood v Casey

      • Introduced in House (01/03/1991)​

      • Freedom of Choice Act of 1991 - Provides that a State may not restrict the right of a woman to choose to terminate a pregnancy: (1) before fetal viability; or (2) at any time, if such termination is necessary to protect the life or health of the woman. Allows a State to impose requirements medically necessary to protect the life or health of such women.​

      • ​permitted states to restrict abortion as long as such restrictions do not place an “undue burden” on women seeking abortion.

      • Undue burden: “whether in a large fraction of the cases in which [the restriction] is relevant, it will operate as a substantial obstacle to a woman’s choice to undergo an abortion.” ​

  • Explain the current abortion provision landscape in the State of Ohio​

    • HB 153​ :Bans public facilities from providing non-therapeutic abortions.​

    • SB 127​: Bans abortions after 20 weeks post-fertilization.​ 22 weeks since a a pregnant person’s last menstrual period.

    • HB 214​: Prohibits performing an abortion if sought wholly or in part due to a prenatal diagnosis of Down syndrome diagnosis. ​

  • Describe the implications of abortion legislation changes on Emergency Medicine ​

    • Dobbs v Jackson

      • Case involved a Mississippi law that banned abortions at 15 weeks ​

      • June 24, 2022: SCOTUS ruled the US constitution does not confer a right to abortion. No longer protected under the 14th amendment. Abortion regulation returned to the states.​

      • ORC 2919.19-.199: Criminalizes abortion when a fetal heartbeat has been detected, except to prevent the death or serious risk of substantial and irreversible impairment of the pregnant woman.​

        • Passed and enjoined 2019​

        • Injunction lifted shortly following SCOTUS ruling​

        • Heart Beat Laws

          • Bans abortion after detection of cardiac activity​

          • Exceptions: Prevent the death of the woman or prevent serious risk of substantial and irreversible impairment of a major bodily function. No exceptions for mental illness. No exceptions for rape or incest. ​

          • Apply only to “intrauterine pregnancies”​

          • Violation charges to provider NOT patient​

          • Charges include felony, fine and loss of license

    • Post Dobbs Abortion Care

      • Planned Parenthood in Cincinnati is OPEN and providing abortions prior to cardiac activity​

        • Transvaginal ultrasound has to be used to assess cardiac activity​

        • Has to be confirmed immediately prior to procedure/MAB​

        • Providing both medication and procedure abortions​

        • Abortion can be done without a confirmed IUP​

      • Referring patients out of state ​

        • No laws against counseling or referring out of state—you can give patient’s Planned Parenthood or other abortion services referral information​

        • Closest referral states are IL, MI, PA​

    • Emergency Medicine Implications

      • Pregnancies, miscarriage, post-abortion, pre-viability demise, high-risk pregnancies​

      • Premature deliveries, medically complex neonates​

      • Confirmation of abortion​

      • Patients with limited access to healthcare​

      • Potential for criminalization

      • Privacy 

        • Strictly limits information that may be provided regarding a patient​

        • Limits a hospital or health care provider’s disclosure of information to law enforcement regarding an abortion​

        • Preempts any State privacy law that is less restrictive than federal law​

        • “According to major professional societies, including the American Medical Association and American College of Obstetricians and Gynecologists, it would be inconsistent with professional standards of ethical conduct to make such a disclosure of PHI to law enforcement or others regarding an individual’s interest, intent, or prior experience with reproductive healthcare.”​

      • EMTALA

        • The EMTALA statute requires that all patients receive an appropriate medical screening, stabilizing treatment, and transfer, if necessary, irrespective of any state laws or mandates that apply to specific procedures.​

        • Any state that has a more restrictive definition of emergency medical condition or that has a definition that directly conflicts with any definition above is preempted by the EMTALA statute. Physicians and hospitals have an obligation to follow the EMTALA definitions, even if doing so involves providing medical stabilizing treatment that is not allowed in the state in which the hospital is located. Hospitals and physicians have an affirmative obligation to provide all necessary stabilizing treatment options to an individual with an emergency medical condition.​

  • Self Managed abortions

    • Self-managed abortion(SMA) refers to any action to end a pregnancy outside of the formal healthcare system.​

    • SMA methods can include​

      • Self sourcing mifepristone and misoprostol or misoprostol alone​

      • Consumption of herbs or botanicals​

      • Ingestion of toxic substances​

      • Use of physical methods​

    • Some people may never interact with the formal healthcare system, during this process but some may interact with clinicians before, during or after their abortion.​

    • It is important for medical professionals to be aware of the expected course of SMA with medications, its rare complications and of other less safe methods.​

    • Approximately 7% of individuals in the US attempt SMA at some point in their life​

    • Rates higher in people who experience higher barriers to abortion care:​

      • People of color​

      • People with lower incomes​

      • People who live in states with restrictive abortion laws​

      • Other reasons: cost, distance, autonomy, convenience, experiencing prior stigma and racism within healthcare system​

    • Legal Risk

      • Medical risks of SMA are low but LEGAL RISKS for people attempting SMA may be significant​

      • NO laws exist in Ohio that require reporting of SMA or suspected SMA​

      • Utilize a harm reduction framework when interacting with these patients​

      • Consider documentation in EMR carefully. Medical records can be subpoenaed

  • Resources


Wilderness Medicine Workshop WITH Dr. Roche

  • The Wilderness Medical Kit with Dr. Otten

    • Before putting together a medical kit for wilderness travel you must ask yourself several important questions: 

      • What am I able and willing to do in the wilderness setting?

        • level of training and experience

        • malpractice exposure

        • responsibility towards others on trip

      • Where am I going?

        • geography-ocean, mountain, desert, rain forest, combinations

        • seasonal climate-hurricanes, tornadoes, floods, monsoon, dry

        • extremes of climate-altitude, cold, hot, dry, underwater, wet

        • endemic medical problems-malaria, hepatitis, meningitis, polio

        • medical support systems-EMS, hospitals, doctors, hyperbaric

        • transportation within country-ground, air, evacuation

        • political considerations-wars, riots, unfriendly governments

        • legal considerations-medical licensure, controlled drugs

        • hazards-unexploded ordinance, wildfires, animal attacks, insects

      • Who am I going with?

        • how many, how old, how conditioned-children, seniors, obese

        • medical problems of fellow travelers--drug interactions, allergies

        • psychological problems of fellow travelers-risk taking, interactions

        • responsibility for their medical care

        • medical expertise of fellow travelers

      • How long are we staying?

        • amount of supplies and drugs

        • resupply options

        • communications with outside

      • How are we getting there?

        • method of travel-air, ship, train, bus-special medical problems

        • travel options in country-vehicles, animals, safety

        • immunization certificates-yellow fever, etc.

        • who is carrying the medical kit-size, weight, security of contents

      • Where are we eating and sleeping?

        • food and water supply

        • sleeping arrangements-cots, mosquito nets, sleeping bags, tents, etc.

        • sanitary conditions-washing, toilets, laundry, insect control

    • The Medical Kit

      • General Principals 

        • Good quality items, multiple uses for each item, replace as needed or when expired, most items are carried on all trips, add and delete items based on above considerations. Be expedient and adapt what you have to what you need i.e. splints, bandages, airway, etc. Gloves should be carried and used when possible. 

      • Waterproof/ resistant container

        • protect fragile items

        • compartmentalized if possible

        • bright color for easy identification

        • list items included

      • Equipment

        • Swiss Army knife-Swiss champ is best

        • mosquito forceps

        • needle holder

        •  thermometer ( low reading)

        • SAM splint

      • Supplies 

        • Band-Aids

        • Hibiclens sponge

        • adhesive tape 2"

        • cravat (triangular bandage)

        • field dressing 4x7

        • stapler 15 shot

        • sutures (nylon/ absorbable)

        • sponges 4x4

        • safety pins

        • steri strips

        • moleskin 6x6

        • elastic gauze or Co ban

        • syringe 10cc

        • needles, 25G, 18G, 12G

        • plastic bags (sm, med, huge)

        • foley catheter

        • vaseline gauze 4x8

        • super glue

        • duct tape

        • knife blades # 11, # 10

      • Drugs: samples or individual blister packs best 

        • Oral

          • aspirin 325mg

          • diphenhydramine 25mg

          • loperamide 2mg

          • ciprofloxacin 500mg

          • acetazolamide 125mg

          • ibuprofen 400mg

          • dexamethasone 4mg

          • amoxicillin-clavulanate 250mg

          • mefloquine 250mg

          • options-acetaminophen, doxycycline, cefixime, nifedipine, meclizine

        • Parenteral: Protect by securing in foam and SAM Splint

          • epinephrine I : I 000

          • lidocaine 2%

          • ketorolac

          • diphenhydramine

          • options-morphine, prochlorperazine, ceftriaxone, bupivacaine

        • Topical

          • triple antibiotic ointment (Neosporin)-cut, bums, abrasions

          • fluocinolone cream0.2%--dermatitis

          • gentamicin ophth ointment-eye infections, corneal abrasions

          • miconazole cream 2%--fungal infections

          • aloe vera gel--frostbite

          • Cavit dental-lost fillings, broken teeth

          • sunscreen 15-30 SPF

          • DEET insect repellant

          • povidine-iodine solution-antiseptic, water purification

          • oxymetazoline nasal spray-sinus squeeze prevention

      • This is the basic kit and items should be added or deleted depending on the situation. For example aloe vera gel is useful for frostbite but may also help with sunburn or other dermatitis. Acetic acid solution may be included if diving where marine animals with nematocysts are abundant. Intravenous fluids if traveling in hot areas for long periods or with unacclimated individuals. Personal choices concerning drugs and supplies has precedent. Use what you are familiar with and what works for you. 


Symptom Control in Chronic Illness WITH Dr. Kiser

  • Describe the evaluation of acute pain in the context of chronic illness​

    • Prevalence of pain in the ED is between 50-70%

    • Pain is the primary complaint of cancer patients for 10-40% of encounters

    • Pain Pathways 

      • Peripheral Sensitization

        • Damage in the periphery leads to inflammatory response in the dorsal horn and exaggerated pain response

      • Segmental central sensitization

        • Damage at a peripheral site leads to neuroplastic changes at the dorsal horn leading to chronic firing

      • Suprasegmental sensitization

        • Physical damage or No damage leads to neuroplastic changes in the thalamus and cortex causing a continuous pain response in the presence of little or no stimuli. 

    • Pain is multifaceted

      • Biological, social and psychological factors 

    • Barriers to Pain treatment in the ED

      • Delays to seeign providers

      • Delays in medication ordering

      • Delays in medication administration

      • Delays in re-assessment

      • Delays in re-dosing

      • Failure to consider chronic opioid use 

    • Opioid Pain medication

      • Act pre-synaptically to block calcium channels on nociceptive afferent nerves to inhibit the release of neurotransmitters such as substance P and glutamate​

      • Post-synaptically they open potassium channels, hyperpolarizing cell membranes and increasing the required action potential to generate nociceptive transmission​

      • Mu, kappa and delta opioid receptors mediate analgesia both spinally and supraspinally

      • Some opioids can affect serotonin kinetics in presence of other serotonergic agents (tramadol, oxycodone, fentanyl, methadone, dextromethorphan, meperidine, codeine, buprenorphine)​

      • Can lead to serotonin syndrome​

      • Some opioids have activity at NMDA receptor (methadone)​

      • Can cause respiratory depression, hypotension, dysphoria, euphoria, sedation, constipation, nausea, vomiting, pruritis​

      • Opioid induced hyperalgesia can occur​

    • Dose Finding 1

      • Opioid naïve

        • Not receiving chronic opioid therapy dail

      • Opioid tolerate 

        • Morphine 60mg/day​

        • Oxycodone 30mg/day​

        • Dilaudid 8mg/day​

        • Fentanyl 25mcg/hr​

        • Hydrocodone 60mg/day

    • Step 2

      • Dose finding

        • Opiate Niave - use conventional doses

        • Opiate tolerant 

          • Administer IV opioid dose equivalent to 10-20% of the total opioid dose taken in the last 24 hours 

          • Opioid Equivalents

            • Morphine IV 10mg and PO 25mg

            • Fentanyl 0.15

            • Hydrocodone IV NA and 25mg

            • Hydromorphone 2mg IV and 5mg PO

            • Oxycodone 10mg IV and 20mg PO

          • Start at the low end 

          • Keep in mind the weight based dosing is usually more than most Physicians give

          • Communicate with nurses if using very high doses. 

    • Step 3 Reassess pain and relief

      • Every 15-20 minutes for IV 

      • Every 60 mins for PO 

      • If pain is worse then increase dose by 50% 100%

      • If pain is better but still severe then repeat the same dose

      • If pain is better and tolerable continue current dose as a PRN 

    • Other Considerations

      • CKD/CRI/AKI​

        • Avoid morphine and dilaudid or reduce dose by 50-75%​

        • Safest are fentanyl and oxycodone​

      • Alternate routes of administration​

        • American College of Hematology (Brandow et al., 2020) recommends SQ/IN if no IV available​

        • Can give many medications subcutaneously, there are special SQ devices for infusions or frequent boluses but can give via butterfly needle (<2mL) ​

        • Macy catheter​

        • Intranasal fentanyl​

      • Consider PCA for patients requiring frequent dosing​

      • Consider PRN orders 

        • Consider writing PRN dosing​

          • When using low starting doses​

          • When not actively titrating​

          • Once you’ve found effective dose​

        • Must inform nursing of PRN order​

        • Allows nurses to give meds without having to find or interrupt you for orders​

          • Consider for anti-emetics as well​

  • Opioid Adjuncts

    • Acetaminophen​

      • Mechanism of action unknown​

      • Peaks in 30-60 minutes​

      • Equivalent to aspirin for antipyretic and analgesic effects​

      • Does not inhibit platelet function​

      • Hepatic metabolism – caution in liver disease and alcohol abuse​

      • Ofirmev is IV formulation, works well but very expensive​

      • 675-1000mg PO Q8H (PRN)​

      • 675mg PR Q8H (PRN)​

      • Max dose 4000mg (3000mg OTC)​

    • NSAID’s​

      • COX-1 and COX-2 inhibitors​

        • COX1 important in regulation of blood flow to kidneys and GI tract via prostaglandins. ​

        • COX1 causes platelet aggregation via thromboxane A2 pathway​

        • COX2 has minimal antiplatelet effects, is gastroprotective​

      • Rapid GI absorption, can be delayed by food​

      • Primarily metabolized by kidneys​

      • Have been linked with acute kidney injury, gastritis/gastrointestinal ulcers, serious cardiac events, worsening of underlying CHF​

      • Cancer patients at higher risk for GI and renal injury – use with caution, if at all​

      • Agents

        • Toradol 15mg IV Q6H (PRN)​

        • Ibuprofen 600-800mg PO Q6-8H (PRN)​

        • Naproxen 250-500mg PO Q12H (PRN)​

        • Meloxicam 5-10mg PO daily (PRN)​

        • Consider adding PPI in higher risk patients​

        • Multiple drug-drug interactions, can potentiate adverse effects​

    • Carbamazepine, Gabapentin, Pregabalin​

      • Indicated for neuropathic pain, takes 1-4 weeks to reach full effect

      • Significant adverse effects can limit use

      • Carbamazepine

        • Limited evidence of efficacy, mostly in trigeminal neuralgia​

        • Mechanism of action unknown​

        • Adverse effects limit use (somnolence, rash)​

        • Start 100mg PO BID of either IR or ER forms​

          • Can increase by 200mg/day​

          • Maximum 1200mg/day​

          • Requires renal dose adjustment​

      • Gabapentin

        • Best evidence in post-herpetic neuralgia, diabetic peripheral neuropathy​

        • Limited support for use in other neuropathic conditions​

        • Blocks voltage dependent calcium channels modulating excitatory neurotransmitter release​

        • Adverse effects limit use (somnolence, dizziness, leg edema, gait disturbance)​

          • Will lessen over 10 days or so​

        • Start 300mg PO QD x 1 day then 600mg PO BID x 1 day then 300mg PO TID​

          • Maximum dose 3600mg/day​

          • Must taper if stopping​

          • Must adjust dose in renal disease or avoid altogether​

      • Pregabalin

        • Binds alpha2 and delta subunit of calcium channels reducing neurotransmitter release​

        • Reasonable evidence for use in postherpetic neuralgia, painful diabetic neuralgia, mixed or peripheral post-traumatic neuralgia​

        • No evidence for benefit in HIV neuropathy​

        • Minimal evidence to support use in central neuropathy​

        • Adverse effects include dizziness, somnolence, constipation, peripheral edema​

        • Start 50mg PO TID, can increase to 100mg PO TID after 1 week​

          • Maximum dose 600mg/day​

          • Must wean off, abrupt withdrawal can cause seizures​

          • Must adjust dose in renal disease, or avoid altogether​

    • Steroids​

      • Anti-inflammatory, but exact mechanism in pain control unknown​

      • Weak evidence to show benefit but is standard of care in several oncology indications (Cochrane Review, Haywood, 2015) ​

        • Brain, bone, liver lesions​

      • Dexamethasone most commonly used, lowest mineralocorticoid effect and long half life​

      • Maximum benefit within 5-7 days​

      • Need long, slow wean if decreasing or stopping​

      • Both short term and long term adverse effects​

        • Short: thrush, edema, dyspepsia, PUD, insomnia, delirium, anxiety, glucose intolerance​

        • Long: adrenal suppression, moon facies/fat redistribution, infection, osteoporosis, skin fragility and impaired wound healing​

      • Discuss with oncology before starting*, may disqualify from clinical trials​

      • Dexamethasone 16mg PO daily​

        • Can give 10mg IVP in ED​

        • Can divide PO doses to avoid stomach upset but watch timing of 2nd dose​

      • Methylprednisolone 16mg PO BID​

      • Prednisone 20-30mg PO BID-TID

    • Ketamine​

      • NMDA receptor antagonist​

      • Can use to avoid opioids or augment them​

      • Evidence supports use with or without opioids in acute pain (Schwenck, 2018) ​

      • No great studies in cancer specific pain (Cochrane Review, Bell, 2017)​

      • Adverse effects: nausea, vomiting, emergence delirium at higher doses, HTN, tachycardia​

      • 0.1-0.3mg/kg IV, 0.5-1mg/kg IN, avoid with hepatic impairment​

      •  PO is being used  in outpatient PC​

    • Muscle relaxants​

      • Spasticity 

        • Increased tone caused by increased excitability of muscle stretch​

        • Stiff, hyperreflexic ​

        • Central disorder of upper motor neurons​

        • MS, TBI, CP, CVA, motor neuron disease​

      • Spasm 

        • Involuntary muscle contractions, often painful and sometimes palpable​

        • A peripheral process but can have systemic or peripheral cause​

        • Multiple causes: muscle injury, peripheral nerve inflammation, stress, electrolyte disturbance, dehydration​

      • Baclofen

        • First line therapy in spasticity​

        • GABA agonist at the spinal cord level​

        • Limited crossing of blood brain barrier so higher doses often needed​

        • Start 5mg PO TID, can increase by 15mg/day to maximum 80mg/day​

        • Adverse effects: somnolence, dizziness, constipation, insomnia​

        • Abrupt cessation can cause withdrawal​

        • Consider decreasing dose in renal disease​

      • Tizanidine

        • Alpha2 agonist, increases presynaptic inhibition of neurons​

        • Sometimes used for additive effects with baclofen​

        • 2mg PO TID, can increase 2-4mg/dose to maximum 36mg/day​

        • Adverse effects: somnolence, dry mouth​

        • Abrupt cessation can cause withdrawal​

        • Decrease dose in both liver and renal disease​

      • Diazepam

        • Works postsynaptically on GABA receptors causing CNS depression​

        • 2-10mg PO TID-QID, 5-10mg IVP Q3-4H PRN​

        • Adverse effects: somnolence, dizziness, respiratory depression, confusion​

        • Abrupt cessation can cause withdrawal​

        • Consider decreased dosing with liver disease​

      • Methocarbamol

        • Unknown mechanism of action​

        • Centrally acting but works better for spasm​

        • 500-750mg PO QID, maximum 6000mg/day​

        • 1000mg IVP Q8H, maximum 3000mg/day​

        • Contraindicated in renal failure (polyethylene glycol)​

        • Requires renal dosing adjustments​

        • Adverse effects: sedation, dizziness, headache, confusion, falls​

        • Case reports of seizures after IV administration in patients with seizure d/o or polysubstance intoxication​

      • Cyclobenzaprine

        • Centrally acting, structurally related to TCA’s but exact mechanism unknown​

        • Indicated for muscle spasm​

        • 5-10mg PO TID, maximum dose 30mg/day​

        • Adverse effects: somnolence, dizziness, confusion, anticholinergic effects​

    • Topicals​

      • Lidocaine Patch

        • Blocks voltage gated sodium channels to prevent nerve from firing​

        • No great evidence to support use in neuropathic pain, but individual studies and clinical experience support use (Cochrane Review, Derry, 2014)​

        • 4% OTC, 5% Rx​

        • 12 hours on, 12 hours off​

        • Can cause rash and local erythema​

      • Capsasin

        • Reduces substance P from nerve endings reducing pain​

        • Found in chili peppers​

        • High concentration (8% patch, Qutenza) more effective than lower dose creams (Cochrane Review, Derry, 2017)​

        • FDA approved in US but difficult to find​

        • Low concentration (0.025, 0.075% cream) similar to placebo (Cochrane Review, Derry, 2012)​

        • Indications for postherpetic neuralgia, HIV neuropathy, peripheral neuropathy​

        • Can cause local irritation​

    • TCA’s​

      • Inhibit presynaptic reuptake of serotonin and norepinephrine, also likely NMDA blockade​

      • Amitriptyline​

        • Best studied​

        • Limited quality evidence but long history of successful use (Cochrane Review, Moore, 2015)​

        • Effective at lower doses than antidepressant dosing (25-75mg QHS)​

        • Indications in peripheral neuralgia​

        • Both anticholinergic and antihistamine adverse effects​

        • Can lower seizure threshold at higher doses and prolong QTc​

        • Life threatening in overdose​

      • Nortriptyline, imipramine, desipramine are all effective as well​

      • Takes 6-8 weeks to achieve maximum affect​

      • Probably best left to physicians with ongoing relationship to start ​

    • SNRI’s​

      • Good evidence to support use in diabetic peripheral neuropathy, less so in fibromyalgia (Cochrane Review, Lunn, 2014)​

      • Potent and selective inhibitor of serotonin and norepinephrine reuptake inhibitor​

      • Start 60mg daily, will need to be increased to 120 mg daily in 2 weeks​

      • Adverse effects: headaches, drowsiness, fatigue, serotonin syndrome​

      • Contraindicated with current or recent MAOI use​

      • Consider lower dose in renal insufficiency, avoid in chronic liver disease​

    • Systemic Lidocaine ​

      • Attenuates peripheral nociceptors sensitization and central hyperexcitability through its sodium channel blocking action​

      • Has pain relief and anti-inflammatory effects in central and peripheral neuropathic pain, less evidence for cancer related pain (Kandil, 2017; Golzari, 2014)​

      • 1-2 mg/kg as a bolus over 10 minutes, we have done continuous drips in PC​

      • Adverse effects: Perioral numbness, dizziness, dysarthria, tachycardia, tremor​

      • Avoid in chronic liver disease​

      • Not a destination therapy but can be useful in terminal patients or to break a pain cycle​